SUN Pharmaceutical Industries Limited Imipenem Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Imipenem Export Records India — #2 Exporter, 119 Shipments, $6.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Imipenem

India Pharmaceutical Trade Intelligence

$33.3M140 Suppliers94 CountriesHS 30049099

ExportsIndia → MEXICO27.2%India → BELGIUM10.0%

ImportsUNITED KINGDOM → India$131.3K UNITED STATES → India$111.3K

#1 Supplier: VENUS REMEDIES

SUN Pharmaceutical Industries Limited — Imipenem Exporter #2 | $6.0M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Imipenem Exporter Profile

Indian Pharmaceutical Exporter · #2 for Imipenem · $6.0M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #2 Indian exporter of Imipenem with $6.0M in export value and 119 verified shipments. SUN Pharmaceutical Industries Limited holds a 17.8% market share in Imipenem exports across 17 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Imipenem Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Imipenem export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Imipenem?

Country	Value	Shipments	Share
BELGIUM	$1.7M	39	30.4%
MOROCCO	$1.1M	25	19.6%
MYANMAR	$509.1K	11	9.1%
NETHERLANDS	$497.8K	11	8.9%

Who Are the Top Buyers of Imipenem from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$1.3M	31
M/S. SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$529.4K	12
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$350.0K	7
M/S. HAPHARCO J.S.C BRANCH	VIETNAM	$288.4K	6
M S HAPHARCO J S C BRANCH	VIETNAM DEMOCRATIC REP OF	$250.0K	5
MS SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$222.9K	5
IDA FOUNDATION THE NETHERLANDS	NETHERLANDS	$200.0K	4
M S RANBAXY PHARMACEUTICALS PTY LTD	SOUTH AFRICA	$200.0K	4
M/S. JDS CO., LTD.	MYANMAR	$144.0K	3
MSSUN PHARMACEUTICALS MOROCCO LLC	MOROCCO	$143.3K	3

SUN Pharmaceutical Industries Limited supplies Imipenem to 49 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by M/S. SUN PHARMACEUTICALS MOROCCO LL (MOROCCO) and YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Imipenem Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
IMIPENEM/CILASTATIN POWDER FOR SOLUTION	$256.9K	6
IMIPENEM+CIL BASICS-S INJ 500MG PACK: 10	$150.0K	3
IMIPENEM & CILASTATIN FOR INJECTION 500MG ( IMIPENEM+CIL RXY INJ 500MG ) PACK :1 VIAL BATCH : DFF2081A EACH VIAL CONTS:	$145.5K	3
IMIPENEM/CILASTATIN POWDER FOR SOLUTIONFOR INFUSION 500MG/500MG (EACH VIAL CONT. IMIPENEM 500MG, CILASTATIN 500MG) [PAC	$140.9K	3
IMIPENEM CILASTATINE INJ 500MG/500MG (IM	$100.0K	2
IMIPENEM CILASTATIN POWDER FOR SOLUTION	$100.0K	2
IMIPENEM CILASTATIN POWDER FOR SOLUTIONFOR INFUSION 500 500MG EACH VIAL CONTAINS IMIPENEM 500MG CILASTATIN 500MG PACK	$100.0K	2
CILAPEN INJ 500MG 100ML PACK:100ML BOTTBATCH:DFE5211A EACH VIAL CONTS. IMIPENEMEQ TO 500MG & CILASTATIN 500MG	$100.0K	2
BACQURE INJ.500MG EACH VIAL CONT IMIPENEM PH EUR/USPSTERILEEQ.TO ANHYDROUS IMIPENEM 500MG CILASTATIN SODIUM PH.EUR/USP	$100.0K	2
BACQURE INJECTION 500MG PACK : 1 Vial Batch : DFG1535D EACH VIAL CONTAINS IMIPENEM PH, EUR/USP (STERILE) EQUIVALENT TO	$100.0K	2

SUN Pharmaceutical Industries Limited exports 109 distinct Imipenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IMIPENEM/CILASTATIN POWDER FOR SOLUTION with 6 shipments worth $256.9K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Imipenem Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	VENUS REMEDIES LIMITED	$9.7M	194	27	$50.0K
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$6.0M	119	17	$50.0K
5	PROTECH BIO SYSTEMS PRIVATE LIMITED	$950.0K	19	2	$50.0K
4	SUN PHARMACEUTICAL INDUSTRIES LTD	$750.0K	15	8	$50.0K

SUN Pharmaceutical Industries Limited ranks #2 among 140 Indian Imipenem exporters. Average shipment value of $50.0K compared to the market average of $143.4K. The closest competitors by value are VENUS REMEDIES LIMITED and PROTECH BIO SYSTEMS PRIVATE LIMITED.

Which Indian Ports Ship Imipenem Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	114	14.2%
DELHI AIR	83	10.3%
SAHAR AIR	76	9.5%
SAHAR AIR CARGO ACC (INBOM4)	57	7.1%
NHAVA SHEVA SEA (INNSA1)	37	4.6%
Delhi Air	34	4.2%
DHANNAD ICD	30	3.7%
DHANNAD ICD (INDHA6)	27	3.4%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Imipenem Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Imipenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 134 individual customs records matching SUN Pharmaceutical Industries Limited exporting Imipenem, covering 109 formulations to 19 countries via 49 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 94+ countries, 302+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Imipenem

Imipenem

SUN Pharmaceutical Industries Limited — Imipenem Exporter Profile

SUN Pharmaceutical Industries Limited — Imipenem Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Imipenem?

Who Are the Top Buyers of Imipenem from SUN Pharmaceutical Industries Limited?

What Is India's Total Imipenem Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Imipenem Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Imipenem Exporters?

What Imipenem Formulations Does SUN Pharmaceutical Industries Limited Export?

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Imipenem Exporters?

Which Indian Ports Ship Imipenem Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Imipenem Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Imipenem Export Data from SUN Pharmaceutical Industries Limited

Imipenem Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source